慢性病患者使用加热烟草制品:2019 年 JASTIS 研究。

Use of heated tobacco products by people with chronic diseases: The 2019 JASTIS study.

机构信息

Department of Hygiene and Public Health, Kansai Medical University, Hirakata-shi, Osaka, Japan.

Cancer Control Center, Osaka International Cancer Institute, Osaka-shi, Osaka, Japan.

出版信息

PLoS One. 2021 Nov 18;16(11):e0260154. doi: 10.1371/journal.pone.0260154. eCollection 2021.

Abstract

Heated tobacco products (HTPs) have become popular recently. People with chronic disease, such as diabetes, cardiovascular disease (CVD), chronic obstructive pulmonary disease (COPD) and cancer, should quit smoking for treatment and recurrence of tobacco-related diseases. However, they have difficulty in quitting smoking, and they may start HTPs use to quit smoking. The purpose of this study is to examine the use of HTPs in people with chronic disease. We used data from an internet study, the Japan Society and New Tobacco Internet Survey (JASTIS). We analyzed 9,008 respondents aged 15-73 years in 2019 using logistic regression. Current use of tobacco products was defined as use within the previous 30 days. Prevalence of current HTP use including dual use and dual use with cigarettes was 9.0% and 6.1% respectively in total. By disease: hypertension 10.2% and 7.4%, diabetes 15.9% and 12.3%, CVD 19.2% and 15.7%, COPD 40.5% and 33.3%, and cancer 17.5% and 11.9%. Diabetes, CVD, COPD, and cancer were positively associated with current use of HTPs (odds ratios (ORs) and 95% confidence intervals (CIs): 1.48 (1.06, 2.07), 2.29 (1.38, 3.80), 3.97(1.73, 9.11), and 3.58(1.99, 6.44), respectively) and dual use of cigarettes and HTPs (ORs and 95% CIs: 2.23 (1.61, 3.09), 3.58 (2.29, 5.60), 7.46 (3.76, 14.80), and 2.57 (1.46, 4.55), respectively) after adjusting for confounders. People with chronic disease were more likely to use HTPs and HTPs together with cigarettes. Further research on the smoking situation of HTPs in patients with chronic diseases is necessary.

摘要

加热烟草制品(HTP)最近变得很流行。患有慢性病的人,如糖尿病、心血管疾病(CVD)、慢性阻塞性肺疾病(COPD)和癌症,应该为了治疗和预防烟草相关疾病而复吸。然而,他们很难戒烟,可能会开始使用 HTP 来戒烟。本研究的目的是调查慢性病患者使用 HTP 的情况。我们使用了来自互联网研究,即日本社会与新烟草互联网调查(JASTIS)的数据。我们使用逻辑回归对 2019 年 9008 名年龄在 15-73 岁的受访者进行了分析。目前使用烟草制品的定义为过去 30 天内使用过。总的来说,目前 HTP 使用包括双重使用和与香烟的双重使用的患病率分别为 9.0%和 6.1%。按疾病划分:高血压为 10.2%和 7.4%,糖尿病为 15.9%和 12.3%,CVD 为 19.2%和 15.7%,COPD 为 40.5%和 33.3%,癌症为 17.5%和 11.9%。糖尿病、CVD、COPD 和癌症与目前使用 HTP 呈正相关(比值比(OR)和 95%置信区间(CI):1.48(1.06,2.07)、2.29(1.38,3.80)、3.97(1.73,9.11)和 3.58(1.99,6.44))以及香烟和 HTP 的双重使用(OR 和 95%CI:2.23(1.61,3.09)、3.58(2.29,5.60)、7.46(3.76,14.80)和 2.57(1.46,4.55)),在调整了混杂因素后。患有慢性病的人更有可能使用 HTP 并将 HTP 与香烟一起使用。有必要对慢性病患者使用 HTP 的吸烟情况进行进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed32/8601522/486ef3a2cc21/pone.0260154.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索